teclistamab
genmab,janssen
['teclistamab', 'janssen']
updated data for janssen s #bispecific #teclistamab suggest continued deep and durable responses in the treatment of patients with relapsed or refractory multiple #myeloma; #omniab #asco22 
Offering best-in-class therapeutic antibody discovery technologies since 2012. Please read our Twitter Guidelines at: https://t.co/wfyZlfB5Gi